Literature DB >> 17009101

PKPD model of interleukin-21 effects on thermoregulation in monkeys--application and evaluation of stochastic differential equations.

Rune Viig Overgaard1, Nick Holford, Klaus A Rytved, Henrik Madsen.   

Abstract

PURPOSE: To describe the pharmacodynamic effects of recombinant human interleukin-21 (IL-21) on core body temperature in cynomolgus monkeys using basic mechanisms of heat regulation. A major effort was devoted to compare the use of ordinary differential equations (ODEs) with stochastic differential equations (SDEs) in pharmacokinetic pharmacodynamic (PKPD) modelling.
METHODS: A temperature model was formulated including circadian rhythm, metabolism, heat loss, and a thermoregulatory set-point. This model was formulated as a mixed-effects model based on SDEs using NONMEM.
RESULTS: The effects of IL-21 were on the set-point and the circadian rhythm of metabolism. The model was able to describe a complex set of IL-21 induced phenomena, including 1) disappearance of the circadian rhythm, 2) no effect after first dose, and 3) high variability after second dose. SDEs provided a more realistic description with improved simulation properties, and further changed the model into one that could not be falsified by the autocorrelation function.
CONCLUSIONS: The IL-21 induced effects on thermoregulation in cynomolgus monkeys are explained by a biologically plausible model. The quality of the model was improved by the use of SDEs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17009101     DOI: 10.1007/s11095-006-9143-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Assessing homeostasis through circadian patterns.

Authors:  R A Irizarry; C Tankersley; R Frank; S Flanders
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

2.  A statistical model of the human core-temperature circadian rhythm.

Authors:  E N Brown; Y Choe; H Luithardt; C A Czeisler
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-09       Impact factor: 4.310

3.  Using stochastic differential equations for PK/PD model development.

Authors:  Niels Rode Kristensen; Henrik Madsen; Steen Hvass Ingwersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-02       Impact factor: 2.745

4.  A population-based Bayesian approach to the minimal model of glucose and insulin homeostasis.

Authors:  Kim E Andersen; Malene Højbjerre
Journal:  Stat Med       Date:  2005-08-15       Impact factor: 2.373

Review 5.  The physiology of heat regulation.

Authors:  P Webb
Journal:  Am J Physiol       Date:  1995-04

6.  Individualized model of human thermoregulation for the simulation of heat stress response.

Authors:  G Havenith
Journal:  J Appl Physiol (1985)       Date:  2001-05

Review 7.  Drug-induced hyperthermia.

Authors:  T C Chan; S D Evans; R F Clark
Journal:  Crit Care Clin       Date:  1997-10       Impact factor: 3.598

8.  Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations.

Authors:  Christoffer W Tornøe; Rune V Overgaard; Henrik Agersø; Henrik A Nielsen; Henrik Madsen; E Niclas Jonsson
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

Review 9.  Prostaglandin E2 as a mediator of fever: synthesis and catabolism.

Authors:  Andrei I Ivanov; Andrej A Romanovsky
Journal:  Front Biosci       Date:  2004-05-01

Review 10.  Do fever and anapyrexia exist? Analysis of set point-based definitions.

Authors:  Andrej A Romanovsky
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-06-10       Impact factor: 3.619

View more
  5 in total

1.  Exact Gradients Improve Parameter Estimation in Nonlinear Mixed Effects Models with Stochastic Dynamics.

Authors:  Helga Kristin Olafsdottir; Jacob Leander; Joachim Almquist; Mats Jirstrand
Journal:  AAPS J       Date:  2018-08-01       Impact factor: 4.009

2.  A semi-physiological-based pharmacokinetic/pharmacodynamic model to describe the effects of topotecan on b-lymphocyte lineage cells.

Authors:  Nieves Vélez de Mendizábal; Iván Martínez-Forero; María J Garrido; Eva Bandrés; Jesús García-Foncillas; Cristina Segura; Iñaki F Trocóniz
Journal:  Pharm Res       Date:  2010-01-26       Impact factor: 4.200

3.  An integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancers.

Authors:  Moran Elishmereni; Yuri Kheifetz; Henrik Søndergaard; Rune Viig Overgaard; Zvia Agur
Journal:  PLoS Comput Biol       Date:  2011-09-29       Impact factor: 4.475

4.  Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice.

Authors:  Xi-Ling Jiang; Hong-Wu Shen; Donald E Mager; Stephan Schmidt; Ai-Ming Yu
Journal:  Acta Pharm Sin B       Date:  2016-08-06       Impact factor: 11.413

5.  PK/PD modeling of 5-hydroxytryptophan (5-HTP) challenge test with cortisol measurement in serum and saliva.

Authors:  Zheng Guan; Gabriel Jacobs; Hans van Pelt; Joop M A Van Gerven; Jacobus Burggraaf; Wei Zhao
Journal:  Pharmacol Res Perspect       Date:  2020-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.